Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review

INTRODUCTION: Buprenorphine–naloxone is recommended as a first-line agent for the treatment of opioid use disorder. Although initiation of buprenorphine in the emergency department (ED) is evidence based, barriers to implementation persist. A comprehensive review and critical analysis of both facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozinoff, Nikki, Soobiah, Charlene, Rodak, Terri, Bucago, Christine, Kingston, Katie, Klaiman, Michelle, Poynter, Brittany, Samuels, Glenna, Schoenfeld, Elizabeth, Shelton, Dominick, Kalocsai, Csilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Addiction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477333/
https://www.ncbi.nlm.nih.gov/pubmed/34580102
http://dx.doi.org/10.1136/bmjopen-2021-053207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477333/
https://www.ncbi.nlm.nih.gov/pubmed/34580102
http://dx.doi.org/10.1136/bmjopen-2021-053207

Ejemplares similares